Across TCGA pan-cancer cohorts, ST13P20 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated ST13P20 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ST13P20 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ST13P20 expression acts as an unfavorable survival marker, although some lineages such as ESCA and BRCA show a favorable association.

BLCA, DLBC, and UCEC are the cancer types where ST13P20 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Quartile	IV	0.266	0.621	.002	79	view →
DLBC	DFS	Tertile	III,IV	0.074	0.984	.003	69	view →
UCEC	DFS	Median	All	0.784	0.870	.004	48	view →
ESCA	DFS	Tertile	III,IV	0.665	0.318	.002	24	view →
CHOL	OS	Tertile	III,IV	0.136	0.859	.003	23	view →
SKCM	DFS	Quartile	III,IV	0.288	0.542	.001	23	view →
LUAD	OS	Tertile	All	0.742	0.842	.003	17	view →
UVM	OS	Tertile	All	0.669	0.946	.010	15	view →
ACC	DFS	Median	III,IV	0.297	0.729	.035	6	view →
BRCA	DFS	Quartile	III,IV	0.758	0.428	.041	4	view →
HNSC	DFS	Quartile	All	0.738	0.560	.019	3	view →
LGG	OS	Quartile	All	0.832	0.929	.046	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

Exploration

Same gene, other analysis: ST13P20 tumor-vs-normal RNA expression · all ST13P20 data types